校友书库推荐的第七十五位出书人来啦

著作一

《如何撰写和发表SCI期刊论文 第2版》

本书从实用的角度出发，列举大量实例，并结合一些学者撰写SCI论文时常发生的错误，对SCI论文的构思、投稿以及修改等方面做了详细阐述，特别要重视SCI论文的题目、摘要、图、表和绪论。本书目的是帮助从事自然科学和生命科学研究的工作者，特别是研究生和青年科研工作者，了解和掌握SCI论文的写作原则与技巧，提高其论文的采用率。

著作二

《活过100岁的秘密》

本书用现代科学理论的角度，比较系统、全面阐述了人类老化的表现和原因，指导中、老年人如何建立健康长寿的合理生活方式。本书除了介绍当今有关人类老化的表现和原因的科学知识之外，还用了很大的篇幅介绍了如何进行合理生活方式来维持健康长寿的具体步骤以及注意事项。

编著一

《干细胞临床应用-基础、伦理和原则》

本书主要介绍干细胞研究的基本知识和临床应用的最新成果、汇集各国干细胞应用的管理法规和技术标准、系统讨论干细胞临床应用伦理和原则。

编著二

《实验卒中模型方法学》

本书以实验卒中模型方法学为主，理论为辅的编写特点，系统体现了卒中动物的饲养、麻醉，模型制备、脑血流检测、模型评估方法，以及样本的采集等关键技术与具体操作事项；同时，系统归纳了目前常用的卒中动物模型，并对其优缺点进行了分析、阐述；进而介绍了与卒中相关的其他脑血管疾病模型，小动物常用生理、生化指标，用药剂量的估计和统计方法等内容。

《Bone Marrow Stem Cell Therapy for Stroke》

This book covers recent advances in all aspects of bone marrow-derived stem cells (BMSCs) for stroke treatment, while also providing comprehensive information on human clinical trials and animal models of stroke. In addition, it reviews the optimal conditions of transplantation for stroke therapy and potential mechanisms underlying transplanted cell-mediated functional recovery after stroke.

《Traditional Chinese Medicine》

Aging is a natural process of life that affects all humans, and healthy aging is achievable, particularly through integrating the best of Eastern and Western medicine. Traditional Chinese Medicine has a long history in Asian countries, which have antiaging properties and could intervene age-related disorders to enhance quality of life and health in the elderly in China. The book contains 19 chapters. The first chapter describes the anti-aging 18 types of common medicines from the "Shen Nong Ben Cao" that combat age-related disorders. Importantly, Chinese herbs introduced in this book is well-known, and the chemical components have been determined, which have not been contaminated with toxic compounds, heavy metals, pesticides, and microorganisms and may have serious side effects.

《Adult Neurogenesis and Central Nervous System Diseases》

Despite progress in the understanding of molecular mechanisms of neuronal cell death, a widely effective treatment of most central nervous system (CNS) diseases such as Alzheimer's disease and Parkinson's disease remains to be one of the biggest challenges for clinicians of the 21st century. The finding that neurogenesis the development of neurons from neural precursor cells continues to occur in the brains of adult mammals, including humans, raises the intriguing possibility that dead or injured neural cells may be replaced through this process. Such a possibility is based on the facts that endogenous neural stem cells in the discrete regions proliferate in response to brain injuries, like stroke, and neurodegerative diseases, such as Huntington's diseases, and that these disease-induced newborn cells can migrate into damaged brain regions, where they differentiate into functional mature neurons.

作者介绍 / 金坤林

美国北德克萨斯大学终身教授。先后在加利福尼亚大学旧金山分校、匹兹堡大学及Buck老年研究所从事神经干细胞、脑卒中及神经保护机制等方面的研究；主持并参与多项美国NIH基金的研究，发表SCI收录论文132余篇；获专利4项。同时是干细胞、神经化学杂志、脑血流与代谢杂志、细胞老化等28类SCI期刊的特约审稿人。2010年，创办了『老化与疾病』英文杂志，并为该杂志主编。